Industry Conference

A new device is bringing live streaming and video calls to the deep. DIVEVOLK's SeaLink is nominated for a top innovation award for changing the game.

With a novel therapy from newborn heart cells, Secretome Therapeutics heads to J.P. Morgan to showcase its progress against intractable heart failure.

CES 2026 will see the debut of the xLean TR1, a robot vacuum that transforms into a handheld and claims to learn like a human. Is this the future?

Dubai's Unchained Summit pivots Web3 from hype to high finance, gathering top VCs and tech leaders for serious deal-making and partnerships in May 2026.

Syntiant unveils ultra-thin AI chips for hearables and smart remotes, aiming to dominate the booming market for miniaturized intelligent devices.

With a promising schizophrenia drug stalled by FDA requirements and finances tight, Reviva Pharmaceuticals' upcoming presentation is more than just a talk.

Chinese firm launches durable centrifuges for sub-zero climates and announces a major localization strategy to capture a multi-billion dollar market.

With a record AED 3.24 million prize, Abu Dhabi's President's Cup attracts the world's best riders for a five-day spectacle of sport and luxury.

The biotech upstart will present a bold pipeline, including a head-to-head trial against a market leader and a first-in-class autoimmune eye disease therapy.

With a key drill target identified at its Rio Tinto-partnered project in Montana, the junior explorer is poised for a pivotal year in the hunt for copper.

NorthStar Medical Radioisotopes will showcase its revolutionary cancer-fighting isotopes, Ac-225 and Cu-67, at the prestigious J.P. Morgan conference.

A Chinese dance drama fusing martial arts and contemporary dance earns global acclaim, bridging cultural divides from Shenzhen to its sold-out Toronto debut.

A new AI-powered smart console wowed crowds at INTERMOT, attracting interest from Yamaha and Honda and signaling a major shift in motorcycle technology.

A long-time innovator at the foundation, Cory Anderson steps into the CEO role with a vision to accelerate economic mobility for Arkansas's families.

An Indiana biotech prepares for biotech's biggest stage, showcasing a pipeline that offers new hope for chronic endocrine and metabolic disorders.

Beyond vaccines, Strand Therapeutics' programmable mRNA shows stunning success in late-stage cancer, heralding a new age of logic-driven genetic medicine.

As Natuzzi prepares its Q3 results, the luxury furniture maker's costly bet on Italian craftsmanship faces a critical test amid a tough economy.

Beyond the runway hype, AI is now a core driver of commerce. But does it level the playing field or just raise the stakes for everyone involved?

Updated trial results for Lilly's Inluriyo-Verzenio combo extend life without chemo, positioning the firm for dominance in a competitive oncology market.

United Imaging Intelligence's new AI agents can reason, act, and report. But are hospitals ready for the business and ethical hurdles of this new era?